WARF will award 2-5 grants from a $100K pool
Jeanan Yasiri Moe
Director of Strategic Communications and Public Affairs
[email protected] | (608) 960-9892
MADISON, Wis. – The Wisconsin Alumni Research Foundation has launched a fall challenge focused on biomarkers and other tools that help researchers and clinicians evaluate strategies for cancer prevention and treatment. Principal Investigators (PIs) and their teams are invited to submit a brief disclosure form and questionnaire by October 27, 2023.
Projects (even early-stage) that focus on any aspect of oncology diagnostics will be considered, including: novel medical imaging technologies, machine learning and AI tools for diagnosing disease, biomarkers that are blood-based or in tissues, and label-free biomarker detection methods. Proposed research should be completed within a year.
Submissions are due to WARF by October 27. Criteria include:
- Project team must include a PI at UW-Madison or Morgridge Institute for Research
- Concepts must be new (not something previously disclosed to WARF)
- Technical readiness
- Commercial potential
“New technologies for diagnosing cancer or tracking disease progression have the potential to improve outcomes for millions of patients in the U.S. and around the world,” says Erik Iverson, CEO of WARF. “We’re delighted to identify and support UW-Madison innovators tackling the challenge of combating cancer.”
For questions contact Beth Fischer, director of IP, life sciences, at [email protected].
The Wisconsin Alumni Research Foundation (WARF) helps steward the cycle of research, discovery, commercialization and investment for the University of Wisconsin–Madison and provides annual support to the university to advance research and innovation. Founded in 1925 as an independent, nonprofit foundation, WARF manages more than 2,000 patents and an investment portfolio as it funds university research, obtains patents for campus discoveries and licenses inventions to industry. For more information, visit warf.org and view WARF’s Cycle of Innovation.